Pasar al contenido principal

Diseño, síntesis y validación de nuevas moléculas y nanomedicinas para el tratamiento del cáncer y otras enfermedades: desde hipótesis hasta su validación in vivo con modelos animales.

RYC2019-026522-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring the Long-Term Tissue Accumulation and Excretion of 3 nm Cerium Oxide Nanoparticles after Single Dose Administration

  • Ernst, Lena M.
  • Mondragón, Laura
  • Ramis, Joana
  • Gusta, Muriel F.
  • Yudina, Tetyana
  • Casals, Eudald
  • Bastús, Neus G.
  • Fernández-Varo, Guillermo
  • Casals, Gregori
  • Jiménez, Wladimiro
  • Puntes, Víctor F.
Nanoparticle (NP) pharmacokinetics significantly differ from traditional small molecule principles. From this emerges the need to create new tools and concepts to harness their full potential and avoid unnecessary risks. Nanoparticle pharmacokinetics strongly depend on size, shape, surface functionalisation, and aggregation state, influencing their biodistribution, accumulation, transformations, and excretion profile, and hence their efficacy and safety. Today, while NP biodistribution and nanoceria biodistribution have been studied often at short times, their long-term accumulation and excretion have rarely been studied. In this work, 3 nm nanoceria at 5.7 mg/kg of body weight was intravenously administrated in a single dose to healthy mice. Biodistribution was measured in the liver, spleen, kidney, lung, brain, lymph nodes, ovary, bone marrow, urine, and faeces at different time points (1, 9, 30, and 100 days). Biodistribution and urinary and faecal excretion were also studied in rats placed in metabolic cages at shorter times. The similarity of results of different NPs in different models is shown as the heterogeneous nanoceria distribution in organs. After the expectable accumulation in the liver and spleen, the concentration of cerium decays exponentially, accounting for about a 50% excretion of cerium from the body in 100 days. Cerium ions, coming from NP dissolution, are most likely excreted via the urinary tract, and ceria nanoparticles accumulated in the liver are most likely excreted via the hepatobiliary route. In addition, nanoceria looks safe and does not damage the target organs. No weight loss or apathy was observed during the course of the experiments., This research was obtained the financial support from the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU) (RTI2018-099965-B-I00, AEI/FEDER, UE) proyectos de I + D + I de programación conjunta internacional MCIN/AEI (CONCORD, PCI2019-103436) co-funded by the European Union and Generalitat de Catalunya (2017-SGR-1431). ICN2 is supported by the Severo Ochoa program from Spanish MINECO (SEV-2017-0706) and is funded by the CERCA Programme/Generalitat de Catalunya. L.M. thanks the financial support from AGAUR by means of the Grants for the incorporation of post-doctoral research staff into the Catalan science and technology system within the Beatriu de Pinós program (Grant No. 2016 BP 00350) and MICINN through the Ramón y Cajal program (RYC2019-026522-I). We would like to thank the Chemical Analysis Service at Autonomous University of Barcelona (SAQs, UAB, Barcelona, Spain) for the Ce content analysis developed. We acknowledge financial support from Dirección General de Investigación Científica y Técnica (Ministerio de Ciencia, Innovación y Universidades (RTI2018-094734-B-C21, to W. Jiménez), and Insituto de Salut Carlos III (FIS PI19-00774, to G. Casals and G. fernández-Varo)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring the Long-Term Tissue Accumulation and Excretion of 3 nm Cerium Oxide Nanoparticles after Single Dose Administration

  • Ernst, Lena M.|||0000-0002-5713-7513
  • Mondragón, Laura|||0000-0002-3257-045X
  • Ramis, Joana
  • Freixanet Gustà, Muriel|||0000-0001-9872-3079
  • Yudina, Tetyana
  • Casals, Eudald|||0000-0002-2900-7295
  • Bastús, Neus G.|||0000-0002-3144-7986
  • Fernández-Varo, Guillermo|||0000-0002-7776-3300
  • Casals, Gregori|||0000-0002-3271-1371
  • Jiménez, Wladimiro|||0000-0002-9376-0214
  • Puntes, Víctor|||0000-0001-8996-9499
Nanoparticle (NP) pharmacokinetics significantly differ from traditional small molecule principles. From this emerges the need to create new tools and concepts to harness their full potential and avoid unnecessary risks. Nanoparticle pharmacokinetics strongly depend on size, shape, surface functionalisation, and aggregation state, influencing their biodistribution, accumulation, transformations, and excretion profile, and hence their efficacy and safety. Today, while NP biodistribution and nanoceria biodistribution have been studied often at short times, their long-term accumulation and excretion have rarely been studied. In this work, 3 nm nanoceria at 5.7 mg/kg of body weight was intravenously administrated in a single dose to healthy mice. Biodistribution was measured in the liver, spleen, kidney, lung, brain, lymph nodes, ovary, bone marrow, urine, and faeces at different time points (1, 9, 30, and 100 days). Biodistribution and urinary and faecal excretion were also studied in rats placed in metabolic cages at shorter times. The similarity of results of different NPs in different models is shown as the heterogeneous nanoceria distribution in organs. After the expectable accumulation in the liver and spleen, the concentration of cerium decays exponentially, accounting for about a 50% excretion of cerium from the body in 100 days. Cerium ions, coming from NP dissolution, are most likely excreted via the urinary tract, and ceria nanoparticles accumulated in the liver are most likely excreted via the hepatobiliary route. In addition, nanoceria looks safe and does not damage the target organs. No weight loss or apathy was observed during the course of the experiments.